Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
American Journal of Physiology. Endocrinology and Metabolism|November 6, 2014
MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exerciseAbdelkrim Khadir, Ali Tiss, Jehad Abubaker, et al.Frontiers in Public Health|June 27, 2022
Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in AdolescentsHend Alqaderi, Fahad Hegazi, Fahd Al-Mulla, et al.Plos One|October 3, 2013
Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesityMohamed Abu-Farha, Ali Tiss, Jehad Abubaker, et al.RSC Advances|April 28, 2022
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspectiveAbbas Khan, Jianjun Gui, Waqar Ahmad, et al.The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern populationJehad Abubaker, Zeenath Jehan, Prashant Bavi, et al.Frontiers in Pharmacology|December 28, 2020
Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and ThromboembolismMohamed Abu-Farha, Salman Al-Sabah, Maha M Hammad, et al.Plos One|July 30, 2013
DNAJB3/HSP-40 cochaperone is downregulated in obese humans and is restored by physical exerciseJehad Abubaker, Ali Tiss, Mohamed Abu-Farha, et al.Diabetes/Metabolism Research and Reviews|March 29, 2023
Plasma insulin is required for the increase in plasma angiopoietin-like protein 8 in response to nutrient ingestionMohamed Abu-Farha, Mariam Alatrach, Jehad Abubaker, et al.The American Journal of Pathology|April 26, 2011
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinomaPrashant Bavi, Shahab Uddin, Maqbool Ahmed, et al.Frontiers in Medicine|July 21, 2022
Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational StudyMohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, et al.Pageof 17